Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Eight-week, Randomized, Double-blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 mg Per Day in Patients Hospitalized for Severe Depression

NCT02229825 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02229825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02229825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Eight-week, Randomized, Double-blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 mg Per Day in Patients Hospitalized for Severe Depression
Lead sponsor
Boehringer Ingelheim
Phase
Phase 4
Overall status
Completed
Start date
February 9, 2007
Completion date
August 26, 2008
Enrollment
339 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major